A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery
Phase of Trial: Phase II/III
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Difelikefalin (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Cara Therapeutics
- 15 Mar 2018 According to a Cara Therapeutics media release, this study is nearing enrollment completion and data from this trial are expected in the second quarter of 2018.
- 06 Feb 2018 Planned End Date changed from 2 Feb 2018 to 1 Jun 2018.
- 06 Feb 2018 Planned primary completion date changed from 29 Dec 2017 to 1 Apr 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History